| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | CDK20 ERBB2 CDKL2 ROR2 LRRK2 OBSCN PEAK3 BRAF PDIK1L GUCY2D ALPK3 PRKDC PINK1 | 1.89e-04 | 600 | 133 | 13 | GO:0004672 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.19e-04 | 18 | 133 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.62e-04 | 4 | 133 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDK20 ERBB2 CDKL2 ROR2 LRRK2 OBSCN PEAK3 BRAF PIK3CD PDIK1L GUCY2D ALPK3 PRKDC PINK1 | 2.76e-04 | 709 | 133 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | actin binding | XIRP1 MYO5A LRRK2 SLC4A1 SPTBN4 WASH3P CORO2B MAP1S XIRP2 SYNE2 GMFB | 3.68e-04 | 479 | 133 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | ankyrin binding | 4.64e-04 | 23 | 133 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | kinase activity | CDK20 ERBB2 CDKL2 ROR2 LRRK2 OBSCN PEAK3 BRAF PIK3CD PDIK1L GUCY2D ALPK3 PRKDC PINK1 | 5.82e-04 | 764 | 133 | 14 | GO:0016301 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 6.49e-04 | 6 | 133 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 7.40e-04 | 363 | 133 | 9 | GO:0106310 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX17 DNAH10 KIF1A TOR2A PSMC2 KIF7 NLRP10 SMARCA4 DDX53 ATP2B3 | 7.51e-04 | 441 | 133 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | XIRP1 KIF1A MYO5A LRRK2 OBSCN SLC4A1 KIF7 SPTBN4 PROM1 WASH3P CORO2B DLC1 MAP1S XIRP2 SYNE2 GMFB HOOK2 | 1.02e-03 | 1099 | 133 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.13e-03 | 31 | 133 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.36e-03 | 33 | 133 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK20 ERBB2 CDKL2 ROR2 LRRK2 OBSCN REV3L PEAK3 BRAF PIK3CD PDIK1L GUCY2D ALPK3 PRKDC PINK1 | 1.47e-03 | 938 | 133 | 15 | GO:0016772 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 1.49e-03 | 34 | 133 | 3 | GO:0050750 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | XIRP1 PCDHA10 PPP1R13L RYR1 RYR2 DLC1 XIRP2 DCHS1 SMARCA4 ROBO2 SMARCD3 ASB2 | 9.99e-07 | 321 | 131 | 12 | GO:0003007 |
| GeneOntologyBiologicalProcess | actin filament-based process | ADCY10 XIRP1 MYO5A CARMIL3 SH3KBP1 OBSCN PEAK3 RYR2 EHD2 SPTBN4 CFLAR WASH3P CORO2B DLC1 BRAF XIRP2 SYNE2 GMFB FGD5 ASB2 | 1.25e-06 | 912 | 131 | 20 | GO:0030029 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | XIRP1 MYO5A ROR2 LRRK2 PCDHA10 PPP1R13L TYMP ITGB4 RYR1 RYR2 RING1 GREB1L CFLAR PROM1 DLC1 BRAF XIRP2 DCHS1 SMARCA4 ROBO2 SMARCD3 PAX2 PAX5 ASB2 | 1.34e-06 | 1269 | 131 | 24 | GO:0009887 |
| GeneOntologyBiologicalProcess | heart development | ERBB2 XIRP1 PCDHA10 PPP1R13L RYR1 RYR2 KIF7 GREB1L FREM2 DLC1 XIRP2 ALPK3 DCHS1 SMARCA4 ROBO2 SMARCD3 PRKDC ASB2 | 1.45e-06 | 757 | 131 | 18 | GO:0007507 |
| GeneOntologyBiologicalProcess | cell junction organization | ERBB2 LRFN1 KIF1A MYO5A DSG1 CARMIL3 ROR2 LRRK2 ITGB4 STAU1 SPTBN4 CORO2B DLC1 PTPRD XIRP2 LRFN5 ROBO2 PATJ CDH6 MPP7 | 3.41e-06 | 974 | 131 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | cardiac chamber development | PCDHA10 PPP1R13L RYR2 KIF7 GREB1L XIRP2 SMARCA4 ROBO2 SMARCD3 | 8.65e-06 | 212 | 131 | 9 | GO:0003205 |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 8.88e-06 | 161 | 131 | 8 | GO:0003231 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 1.04e-05 | 22 | 131 | 4 | GO:0006337 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ADCY10 LRFN1 MYO5A CARMIL3 LRRK2 RMI2 PEAK3 SPTBN4 WASH3P VPS13D CORO2B DLC1 PTPRD MAP1S BRAF XIRP2 SYNE2 SMARCA4 SMARCD1 SMARCD2 GMFB SMARCD3 PINK1 | 1.17e-05 | 1342 | 131 | 23 | GO:0033043 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | XIRP1 MYO5A CARMIL3 SH3KBP1 OBSCN PEAK3 EHD2 SPTBN4 CFLAR WASH3P CORO2B DLC1 BRAF XIRP2 GMFB FGD5 ASB2 | 1.34e-05 | 803 | 131 | 17 | GO:0030036 |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 1.50e-05 | 24 | 131 | 4 | GO:0032986 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 3.26e-05 | 29 | 131 | 4 | GO:2000819 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 4.14e-05 | 146 | 131 | 7 | GO:2000779 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | ERBB2 RC3H1 BRAF SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC | 5.18e-05 | 266 | 131 | 9 | GO:0045619 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ADCY10 ERBB2 KIF1A SH3KBP1 LRRK2 SPART PEAK3 SPTBN4 DLC1 PTPRD MAP1S BRAF SMARCA4 ROBO2 MAEL FGD5 PAX2 PRKDC DNMBP CDH6 | 6.45e-05 | 1194 | 131 | 20 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.00e-04 | 226 | 131 | 8 | GO:0045580 | |
| GeneOntologyBiologicalProcess | circulatory system development | ERBB2 XIRP1 PCDHA10 APOB PPP1R13L TYMP RYR1 RYR2 KIF7 GREB1L CFLAR FREM2 DLC1 XIRP2 PIK3CD ALPK3 DCHS1 SMARCA4 ROBO2 SMARCD3 PRKDC ASB2 | 1.06e-04 | 1442 | 131 | 22 | GO:0072359 |
| GeneOntologyBiologicalProcess | muscle structure development | XIRP1 DDX17 AVPR1A OBSCN RYR1 RYR2 EHD2 CFLAR XIRP2 ALPK3 SMARCA4 SMARCD1 SMARCD2 SMARCD3 PAX5 ASB2 | 1.10e-04 | 858 | 131 | 16 | GO:0061061 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | ADCY10 CARMIL3 PEAK3 RYR2 SPTBN4 WASH3P CORO2B DLC1 BRAF XIRP2 GMFB | 1.13e-04 | 438 | 131 | 11 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | LRRK2 RMI2 CORO2B BRAF SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC TP53BP1 PINK1 NPAS2 | 1.14e-04 | 598 | 131 | 13 | GO:0080135 |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 1.27e-04 | 234 | 131 | 8 | GO:0006282 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | ERBB2 RC3H1 SH3KBP1 LRRK2 SLC4A1 BRAF LRFN5 SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC TP53BP1 | 1.36e-04 | 694 | 131 | 14 | GO:0002694 |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 1.44e-04 | 42 | 131 | 4 | GO:0070316 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | CDK20 ERBB2 XIRP1 RC3H1 ROR2 OBSCN PCDHA10 TYMP ITGB4 PRX EHD2 CFLAR PROM1 DLC1 PIK3CD DCHS1 SMARCA4 ROBO2 SMARCD3 PAX2 PRKDC CDC73 | 1.59e-04 | 1483 | 131 | 22 | GO:0048646 |
| GeneOntologyBiologicalProcess | T cell differentiation | ERBB2 RC3H1 BRAF PIK3CD SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC | 1.67e-04 | 382 | 131 | 10 | GO:0030217 |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | ERBB2 RC3H1 ROR2 BRAF SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC CDC73 CNOT4 | 1.73e-04 | 540 | 131 | 12 | GO:1903706 |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 1.73e-04 | 44 | 131 | 4 | GO:0045023 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | ADCY10 ERBB2 KIF1A RC3H1 SH3KBP1 LRRK2 SPART PEAK3 DLC1 PTPRD BRAF PIK3CD ROBO2 FGD5 PAX2 PRKDC DNMBP PINK1 | 1.85e-04 | 1090 | 131 | 18 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of cell development | ADCY10 ERBB2 RC3H1 ROR2 LRRK2 SPART TRIM11 PTPRD BRAF SMARCA4 SMARCD1 SMARCD2 ROBO2 SMARCD3 DUSP10 PRKDC CDC73 CNOT4 | 1.96e-04 | 1095 | 131 | 18 | GO:0060284 |
| GeneOntologyBiologicalProcess | myoblast differentiation | 2.34e-04 | 136 | 131 | 6 | GO:0045445 | |
| GeneOntologyBiologicalProcess | peripheral nervous system myelin formation | 2.38e-04 | 4 | 131 | 2 | GO:0032290 | |
| GeneOntologyBiologicalProcess | cell junction assembly | LRFN1 DSG1 CARMIL3 ITGB4 CORO2B DLC1 PTPRD LRFN5 ROBO2 PATJ CDH6 MPP7 | 2.79e-04 | 569 | 131 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 3.07e-04 | 143 | 131 | 6 | GO:0045739 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | ERBB2 RC3H1 SH3KBP1 LRRK2 SLC4A1 BRAF LRFN5 SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC TP53BP1 | 3.26e-04 | 756 | 131 | 14 | GO:0050865 |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 3.51e-04 | 95 | 131 | 5 | GO:2000781 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | SH3KBP1 LRRK2 SLC4A1 SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC TP53BP1 | 3.76e-04 | 423 | 131 | 10 | GO:0002696 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | XIRP1 MYO5A CARMIL3 SH3KBP1 OBSCN CCDC57 SPTBN4 CFLAR WASH3P CORO2B DLC1 MAP1S BRAF XIRP2 GMFB HOOK2 | 3.78e-04 | 957 | 131 | 16 | GO:0097435 |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 3.84e-04 | 54 | 131 | 4 | GO:0045663 | |
| GeneOntologyBiologicalProcess | paramesonephric duct development | 3.95e-04 | 5 | 131 | 2 | GO:0061205 | |
| GeneOntologyBiologicalProcess | actin filament organization | XIRP1 MYO5A CARMIL3 SH3KBP1 SPTBN4 WASH3P CORO2B DLC1 BRAF XIRP2 GMFB | 4.10e-04 | 509 | 131 | 11 | GO:0007015 |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | ERBB2 RC3H1 ROR2 BRAF SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC | 4.20e-04 | 429 | 131 | 10 | GO:1902105 |
| GeneOntologyBiologicalProcess | synapse organization | ERBB2 LRFN1 KIF1A MYO5A CARMIL3 ROR2 LRRK2 STAU1 SPTBN4 PTPRD LRFN5 ROBO2 CDH6 | 4.26e-04 | 685 | 131 | 13 | GO:0050808 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | ERBB2 RC3H1 SH3KBP1 SLC4A1 BRAF SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC TP53BP1 | 5.51e-04 | 614 | 131 | 12 | GO:0051249 |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 5.77e-04 | 161 | 131 | 6 | GO:0003206 | |
| GeneOntologyBiologicalProcess | regulation of kidney size | 5.91e-04 | 6 | 131 | 2 | GO:0035564 | |
| GeneOntologyBiologicalProcess | skeletal muscle atrophy | 5.91e-04 | 6 | 131 | 2 | GO:0014732 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 5.96e-04 | 162 | 131 | 6 | GO:0045621 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | SH3KBP1 LRRK2 SLC4A1 SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC TP53BP1 | 5.98e-04 | 449 | 131 | 10 | GO:0050867 |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | ERBB2 RC3H1 BRAF PIK3CD SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC PAX5 | 6.40e-04 | 537 | 131 | 11 | GO:0030098 |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 6.73e-04 | 300 | 131 | 8 | GO:0110053 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 7.16e-04 | 111 | 131 | 5 | GO:0033045 | |
| GeneOntologyBiologicalProcess | hemopoiesis | ERBB2 RC3H1 ROR2 ADAR SLC4A1 CFLAR BRAF PIK3CD SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC PAX5 CDC73 CNOT4 PINK1 | 7.32e-04 | 1223 | 131 | 18 | GO:0030097 |
| GeneOntologyBiologicalProcess | negative regulation of reactive oxygen species metabolic process | 7.35e-04 | 64 | 131 | 4 | GO:2000378 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 7.46e-04 | 112 | 131 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 7.87e-04 | 384 | 131 | 9 | GO:0032956 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | ERBB2 RC3H1 ROR2 BRAF PIK3CD SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC PAX5 | 7.92e-04 | 640 | 131 | 12 | GO:1903131 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | SH3KBP1 SLC4A1 SMARCA4 SMARCD1 SMARCD2 SMARCD3 DUSP10 PRKDC TP53BP1 | 8.01e-04 | 385 | 131 | 9 | GO:0051251 |
| GeneOntologyBiologicalProcess | protein processing involved in protein targeting to mitochondrion | 8.23e-04 | 7 | 131 | 2 | GO:0006627 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell differentiation involved in kidney development | 8.23e-04 | 7 | 131 | 2 | GO:2000698 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle transport | 8.23e-04 | 7 | 131 | 2 | GO:1902803 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | RC3H1 ROR2 SH3KBP1 LRRK2 SLC4A1 TRIM11 NLRP10 BRAF PIK3CD LRCH4 SMARCA4 SMARCD1 SMARCD2 SMARCD3 LRRC14 DUSP10 PRKDC TP53BP1 | 8.74e-04 | 1242 | 131 | 18 | GO:0002684 |
| GeneOntologyBiologicalProcess | organelle assembly | XIRP1 LRFN1 CFAP73 RC3H1 LRRK2 OBSCN CCDC57 HPS3 EHD2 CFLAR WASH3P PTPRD SYNE2 PRKDC ASB2 DNMBP PINK1 | 8.81e-04 | 1138 | 131 | 17 | GO:0070925 |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 9.13e-04 | 242 | 131 | 7 | GO:1903708 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 9.13e-04 | 242 | 131 | 7 | GO:1902107 | |
| GeneOntologyBiologicalProcess | regulation of Arp2/3 complex-mediated actin nucleation | 9.88e-04 | 31 | 131 | 3 | GO:0034315 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 2.27e-05 | 230 | 138 | 9 | GO:0098562 | |
| GeneOntologyCellularComponent | anchoring junction | XIRP1 DSG1 SH3KBP1 OBSCN PCDHA10 PEAK3 PLEKHG5 ITGB4 PRX SLC4A1 SPTBN4 CORO2B DLC1 XIRP2 SYNE2 PATJ DNMBP CDH6 MPP7 | 2.31e-05 | 976 | 138 | 19 | GO:0070161 |
| GeneOntologyCellularComponent | SWI/SNF complex | 4.36e-05 | 30 | 138 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | Z disc | 6.56e-05 | 151 | 138 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | npBAF complex | 9.72e-05 | 14 | 138 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 9.72e-05 | 14 | 138 | 3 | GO:0035060 | |
| GeneOntologyCellularComponent | I band | 1.19e-04 | 166 | 138 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | RSC-type complex | 1.21e-04 | 15 | 138 | 3 | GO:0016586 | |
| GeneOntologyCellularComponent | actomyosin | 1.27e-04 | 117 | 138 | 6 | GO:0042641 | |
| GeneOntologyCellularComponent | nBAF complex | 1.48e-04 | 16 | 138 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 2.32e-04 | 185 | 138 | 7 | GO:0009898 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 2.39e-04 | 46 | 138 | 4 | GO:0005790 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 4.00e-04 | 94 | 138 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | cell-cell junction | XIRP1 DSG1 SH3KBP1 OBSCN PCDHA10 PLEKHG5 SLC4A1 SPTBN4 PATJ DNMBP CDH6 MPP7 | 5.59e-04 | 591 | 138 | 12 | GO:0005911 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 7.23e-04 | 107 | 138 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 7.23e-04 | 107 | 138 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | presynapse | ERBB2 LRFN1 SYN3 KIF1A MYO5A LRRK2 PLEKHG5 ITPR3 AP2M1 PTPRD KCNA6 BRAF DNMBP ATP2B3 SLC30A10 | 7.71e-04 | 886 | 138 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | extrinsic component of membrane | 8.53e-04 | 230 | 138 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SYN3 MYO5A CARMIL3 ROR2 LRRK2 ITGB4 STAU1 AP2M1 PTPRD BRAF LRFN5 ROBO2 ATP2B3 CDH6 | 1.03e-03 | 817 | 138 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | intercalated disc | 1.07e-03 | 68 | 138 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.12e-03 | 118 | 138 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | sarcomere | 1.35e-03 | 249 | 138 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | cell leading edge | ERBB2 MYO5A CARMIL3 PLEKHG5 ITGB4 WASH3P DLC1 SYNE2 ROBO2 FGD5 | 1.81e-03 | 500 | 138 | 10 | GO:0031252 |
| GeneOntologyCellularComponent | bBAF complex | 1.88e-03 | 10 | 138 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 1.88e-03 | 10 | 138 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | supramolecular fiber | DNAH10 KIF1A MYO5A ROR2 OBSCN CCDC57 RYR1 RYR2 SLC4A1 KIF7 SPTBN4 DLC1 MAP1S XIRP2 SYNE2 HOOK2 ASB2 | 1.99e-03 | 1179 | 138 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | DNAH10 KIF1A MYO5A ROR2 OBSCN CCDC57 RYR1 RYR2 SLC4A1 KIF7 SPTBN4 DLC1 MAP1S XIRP2 SYNE2 HOOK2 ASB2 | 2.14e-03 | 1187 | 138 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.17e-03 | 137 | 138 | 5 | GO:0019897 | |
| GeneOntologyCellularComponent | myofibril | 2.28e-03 | 273 | 138 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 2.33e-03 | 40 | 138 | 3 | GO:0005640 | |
| GeneOntologyCellularComponent | actin-based cell projection | 2.52e-03 | 278 | 138 | 7 | GO:0098858 | |
| GeneOntologyCellularComponent | organelle outer membrane | 2.57e-03 | 279 | 138 | 7 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 2.67e-03 | 281 | 138 | 7 | GO:0019867 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.76e-03 | 88 | 138 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.18e-03 | 290 | 138 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 3.26e-03 | 45 | 138 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | cell cortex | 3.28e-03 | 371 | 138 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | GBAF complex | 3.74e-03 | 14 | 138 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.78e-03 | 96 | 138 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | endocytic vesicle | 4.04e-03 | 384 | 138 | 8 | GO:0030139 | |
| GeneOntologyCellularComponent | microtubule associated complex | 4.34e-03 | 161 | 138 | 5 | GO:0005875 | |
| MousePheno | abnormal intercalated disk morphology | 1.22e-05 | 18 | 115 | 4 | MP:0006267 | |
| MousePheno | pigmentation phenotype | CDK20 MYO5A LRRK2 BMS1 OAT ECPAS GTF2IRD1 HPS3 PROM1 FREM2 CORO2B FBXO10 BRAF RBM6 PAX2 PRKDC ATP2B3 | 1.31e-05 | 624 | 115 | 17 | MP:0001186 |
| MousePheno | abnormal muscle contractility | BIRC8 XIRP1 AVPR1A OBSCN PPP1R13L RYR1 RYR2 SLC4A1 SPTBN4 FBXO10 BRAF ALPK3 SMARCD3 | 3.89e-05 | 418 | 115 | 13 | MP:0005620 |
| MousePheno | abnormal myocardial fiber currents | 4.39e-05 | 9 | 115 | 3 | MP:0020345 | |
| Domain | SWIB_domain | 3.69e-07 | 3 | 135 | 3 | IPR019835 | |
| Domain | SWIB | 3.69e-07 | 3 | 135 | 3 | SM00151 | |
| Domain | SWIB | 3.65e-06 | 5 | 135 | 3 | PF02201 | |
| Domain | RIH_assoc-dom | 7.27e-06 | 6 | 135 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 7.27e-06 | 6 | 135 | 3 | PF08709 | |
| Domain | - | 7.27e-06 | 6 | 135 | 3 | 1.10.245.10 | |
| Domain | RIH_assoc | 7.27e-06 | 6 | 135 | 3 | PF08454 | |
| Domain | RIH_dom | 7.27e-06 | 6 | 135 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.27e-06 | 6 | 135 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.27e-06 | 6 | 135 | 3 | IPR015925 | |
| Domain | - | 7.27e-06 | 6 | 135 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.27e-06 | 6 | 135 | 3 | PF01365 | |
| Domain | SWIB_MDM2_domain | 7.27e-06 | 6 | 135 | 3 | IPR003121 | |
| Domain | Kinase-like_dom | CDK20 ERBB2 CDKL2 ROR2 LRRK2 OBSCN PEAK3 BRAF PIK3CD PDIK1L GUCY2D ALPK3 PRKDC PINK1 | 3.88e-05 | 542 | 135 | 14 | IPR011009 |
| Domain | MIR | 4.27e-05 | 10 | 135 | 3 | PF02815 | |
| Domain | MIR_motif | 4.27e-05 | 10 | 135 | 3 | IPR016093 | |
| Domain | MIR | 4.27e-05 | 10 | 135 | 3 | PS50919 | |
| Domain | MIR | 4.27e-05 | 10 | 135 | 3 | SM00472 | |
| Domain | Actin-binding_Xin_repeat | 5.19e-05 | 2 | 135 | 2 | IPR012510 | |
| Domain | XIRP1/XIRP2 | 5.19e-05 | 2 | 135 | 2 | IPR030072 | |
| Domain | XIN | 5.19e-05 | 2 | 135 | 2 | PS51389 | |
| Domain | Xin | 5.19e-05 | 2 | 135 | 2 | PF08043 | |
| Domain | DUF1220 | 5.84e-05 | 11 | 135 | 3 | PF06758 | |
| Domain | NBPF_dom | 5.84e-05 | 11 | 135 | 3 | IPR010630 | |
| Domain | NBPF | 5.84e-05 | 11 | 135 | 3 | PS51316 | |
| Domain | Pax2_C | 1.55e-04 | 3 | 135 | 2 | IPR022130 | |
| Domain | Pax2_C | 1.55e-04 | 3 | 135 | 2 | PF12403 | |
| Domain | Ryanodine_rcpt | 1.55e-04 | 3 | 135 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.55e-04 | 3 | 135 | 2 | IPR009460 | |
| Domain | RyR | 1.55e-04 | 3 | 135 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.55e-04 | 3 | 135 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.55e-04 | 3 | 135 | 2 | IPR013333 | |
| Domain | P-loop_NTPase | ADCY10 DDX17 DNAH10 KIF1A MYO5A TOR2A LRRK2 BMS1 PSMC2 KIF7 EHD2 NLRP10 SMARCA4 DDX53 MPP7 NLRP8 | 4.17e-04 | 848 | 135 | 16 | IPR027417 |
| Domain | Ig_I-set | 4.67e-04 | 190 | 135 | 7 | IPR013098 | |
| Domain | I-set | 4.67e-04 | 190 | 135 | 7 | PF07679 | |
| Domain | FN3 | 6.15e-04 | 199 | 135 | 7 | PS50853 | |
| Domain | ARM-type_fold | 8.11e-04 | 339 | 135 | 9 | IPR016024 | |
| Domain | FN3_dom | 8.22e-04 | 209 | 135 | 7 | IPR003961 | |
| Domain | fn3 | 1.16e-03 | 162 | 135 | 6 | PF00041 | |
| Domain | Calx_beta | 1.41e-03 | 8 | 135 | 2 | SM00237 | |
| Domain | RhoGEF | 1.49e-03 | 68 | 135 | 4 | SM00325 | |
| Domain | CA | 1.49e-03 | 115 | 135 | 5 | SM00112 | |
| Domain | IGc2 | 1.62e-03 | 235 | 135 | 7 | SM00408 | |
| Domain | Ig_sub2 | 1.62e-03 | 235 | 135 | 7 | IPR003598 | |
| Domain | RhoGEF | 1.66e-03 | 70 | 135 | 4 | PF00621 | |
| Domain | DH_2 | 1.66e-03 | 70 | 135 | 4 | PS50010 | |
| Domain | Cadherin | 1.67e-03 | 118 | 135 | 5 | IPR002126 | |
| Domain | - | 1.74e-03 | 71 | 135 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 1.74e-03 | 71 | 135 | 4 | IPR000219 | |
| Domain | Calx_beta | 1.81e-03 | 9 | 135 | 2 | IPR003644 | |
| Domain | PAX | 1.81e-03 | 9 | 135 | 2 | SM00351 | |
| Domain | PAIRED_2 | 1.81e-03 | 9 | 135 | 2 | PS51057 | |
| Domain | PAIRED_1 | 1.81e-03 | 9 | 135 | 2 | PS00034 | |
| Domain | Paired_dom | 1.81e-03 | 9 | 135 | 2 | IPR001523 | |
| Domain | PAX | 1.81e-03 | 9 | 135 | 2 | PF00292 | |
| Domain | Calx-beta | 1.81e-03 | 9 | 135 | 2 | PF03160 | |
| Domain | DUF1220 | 1.81e-03 | 9 | 135 | 2 | SM01148 | |
| Domain | FN3 | 2.28e-03 | 185 | 135 | 6 | SM00060 | |
| Domain | L_dom-like | 2.68e-03 | 328 | 135 | 8 | IPR032675 | |
| Domain | Prot_kinase_dom | 2.95e-03 | 489 | 135 | 10 | IPR000719 | |
| Domain | - | ADCY10 DDX17 DNAH10 TOR2A LRRK2 BMS1 PSMC2 EHD2 NLRP10 SMARCA4 DDX53 MPP7 NLRP8 | 2.95e-03 | 746 | 135 | 13 | 3.40.50.300 |
| Domain | PROTEIN_KINASE_DOM | 3.12e-03 | 493 | 135 | 10 | PS50011 | |
| Domain | Leu-rich_rpt | 3.59e-03 | 271 | 135 | 7 | IPR001611 | |
| Domain | L27 | 3.84e-03 | 13 | 135 | 2 | SM00569 | |
| Domain | L27 | 3.84e-03 | 13 | 135 | 2 | PS51022 | |
| Domain | L27_dom | 3.84e-03 | 13 | 135 | 2 | IPR004172 | |
| Domain | HEAT | 5.04e-03 | 48 | 135 | 3 | PF02985 | |
| Domain | PI3/4_kinase_CS | 5.12e-03 | 15 | 135 | 2 | IPR018936 | |
| Domain | - | 5.56e-03 | 222 | 135 | 6 | 1.25.10.10 | |
| Domain | - | 5.82e-03 | 16 | 135 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.82e-03 | 16 | 135 | 2 | SM00146 | |
| Domain | PROTEIN_KINASE_ATP | 6.19e-03 | 459 | 135 | 9 | PS00107 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 3.84e-06 | 34 | 100 | 5 | MM15531 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.91e-06 | 37 | 100 | 5 | M27797 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 1.12e-05 | 42 | 100 | 5 | M48237 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 4.94e-05 | 29 | 100 | 4 | M48076 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 6.47e-05 | 31 | 100 | 4 | M39522 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 1.05e-04 | 35 | 100 | 4 | M47969 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.06e-04 | 153 | 100 | 7 | MM15522 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 1.79e-04 | 40 | 100 | 4 | MM14936 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.09e-04 | 19 | 100 | 3 | M47760 | |
| Pubmed | 2.15e-10 | 21 | 142 | 6 | 16079250 | ||
| Pubmed | 8.18e-10 | 12 | 142 | 5 | 33723076 | ||
| Pubmed | DDX17 DNAH10 AVPR1A BMS1 EFCAB2 PSMC2 HPS3 VPS13D SYNE2 SYTL1 PATJ GOLGA3 | 1.78e-09 | 277 | 142 | 12 | 30745168 | |
| Pubmed | 9.23e-09 | 7 | 142 | 4 | 28369036 | ||
| Pubmed | 5.49e-08 | 10 | 142 | 4 | 34716243 | ||
| Pubmed | Expression analysis of Baf60c during heart regeneration in axolotls and neonatal mice. | 6.66e-08 | 3 | 142 | 3 | 27125315 | |
| Pubmed | KIF1A MYO5A BMS1 USP24 PSMC2 OAT ECPAS TRIP12 STAU1 ITPR3 SYNE2 RBM6 SMARCA4 PRKDC TP53BP1 | 8.24e-08 | 653 | 142 | 15 | 22586326 | |
| Pubmed | SH3KBP1 AGPAT4 PCDHA10 GTF2IRD1 PRX RYR1 PIK3CD GUCY2D SMARCD1 SMARCD2 SMARCD3 | 1.22e-07 | 329 | 142 | 11 | 17474147 | |
| Pubmed | Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. | 1.85e-07 | 13 | 142 | 4 | 11726552 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | DDX17 CAND2 PMPCB PSMC2 ADAR TRIP12 STAU1 NOP9 AP2M1 MAP1S SMARCA4 SMARCD2 PRKDC CDC73 TP53BP1 | 2.16e-07 | 704 | 142 | 15 | 29955894 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TRIP12 NBPF20 PRX NBPF19 TNRC18 MAP1S XIRP2 NBPF9 CCDC87 PATJ NBPF14 SAP130 | 2.24e-07 | 430 | 142 | 12 | 35044719 |
| Pubmed | MYO5A DSG1 SH3KBP1 ECPAS PPP1R13L DUS3L ADAR PLEKHG5 ZNF24 AP2M1 DLC1 LRCH4 RBM6 SMARCA4 FGD5 PATJ DNMBP | 2.26e-07 | 916 | 142 | 17 | 32203420 | |
| Pubmed | Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. | 2.58e-07 | 14 | 142 | 4 | 8895581 | |
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 3.51e-07 | 15 | 142 | 4 | 11175787 | |
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 3.51e-07 | 15 | 142 | 4 | 17920018 | |
| Pubmed | 3.51e-07 | 15 | 142 | 4 | 11263494 | ||
| Pubmed | DNAH10 MYO5A RC3H1 SH3KBP1 BMS1 PSMC2 UBN2 KIF7 STAU1 RING1 ZNF24 AP2M1 SYNE2 RBM6 SMARCA4 SMARCD1 SMARCD2 SMARCD3 PAX2 SAP130 TP53BP1 | 3.78e-07 | 1429 | 142 | 21 | 35140242 | |
| Pubmed | Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma. | 4.67e-07 | 16 | 142 | 4 | 35390516 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CAND2 KIF1A PMPCB GPX8 BMS1 PSMC2 OAT ECPAS KIF7 ITPR3 AP2M1 PTPRD DUSP10 PRKDC HOOK2 CDC73 MPP7 | 5.30e-07 | 974 | 142 | 17 | 28675297 |
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 9693044 | ||
| Pubmed | BAF complexes facilitate decatenation of DNA by topoisomerase IIα. | 7.80e-07 | 18 | 142 | 4 | 23698369 | |
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 9.84e-07 | 19 | 142 | 4 | 12110891 | |
| Pubmed | 9.84e-07 | 19 | 142 | 4 | 16932743 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.32e-06 | 6 | 142 | 3 | 25966694 | |
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 20519450 | ||
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 23463619 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.32e-06 | 6 | 142 | 3 | 16844763 | |
| Pubmed | Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome. | 1.74e-06 | 49 | 142 | 5 | 27352031 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.94e-06 | 202 | 142 | 8 | 33005030 | |
| Pubmed | ERBB2 MYO5A USP28 ECPAS STAU1 ITPR3 AP2M1 LRCH4 SMARCA4 SMARCD1 SMARCD2 SMARCD3 CDC73 | 2.21e-06 | 634 | 142 | 13 | 34591612 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 2.22e-06 | 23 | 142 | 4 | 30962207 | |
| Pubmed | Genomic variants in an inbred mouse model predict mania-like behaviors. | 2.22e-06 | 23 | 142 | 4 | 29768498 | |
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 2.22e-06 | 23 | 142 | 4 | 8804307 | |
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 11860456 | ||
| Pubmed | 2.66e-06 | 24 | 142 | 4 | 11790558 | ||
| Pubmed | 2.66e-06 | 24 | 142 | 4 | 12215535 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 2.66e-06 | 24 | 142 | 4 | 10078207 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 3.68e-06 | 8 | 142 | 3 | 19033399 | |
| Pubmed | 3.71e-06 | 26 | 142 | 4 | 10778858 | ||
| Pubmed | 4.35e-06 | 27 | 142 | 4 | 29374058 | ||
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 5.05e-06 | 28 | 142 | 4 | 12192000 | |
| Pubmed | 5.23e-06 | 61 | 142 | 5 | 20305087 | ||
| Pubmed | Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. | 5.84e-06 | 29 | 142 | 4 | 15525990 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX17 DNAH10 KIF1A DSG1 PMPCB BMS1 OAT APOB ECPAS ADAR STAU1 NOP9 AP2M1 SMARCA4 FGD5 PRKDC CDC73 ATP2B3 NPAS2 | 5.85e-06 | 1425 | 142 | 19 | 30948266 |
| Pubmed | 6.72e-06 | 30 | 142 | 4 | 31043422 | ||
| Pubmed | 7.60e-06 | 322 | 142 | 9 | 26514267 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 7.83e-06 | 10 | 142 | 3 | 22973535 | |
| Pubmed | 8.55e-06 | 116 | 142 | 6 | 21549307 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 9.09e-06 | 178 | 142 | 7 | 27637333 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ERBB2 KIF1A MYO5A ROR2 OBSCN ECPAS GTF2IRD1 UBN2 CCDC57 HPS3 SPTBN4 EXD3 TNRC18 RBM6 HOOK2 SYTL1 PATJ SAP130 NPAS2 | 1.09e-05 | 1489 | 142 | 19 | 28611215 |
| Pubmed | DDX17 RMI2 ECPAS UBN2 ADAR STAU1 ZNF24 TNRC18 AP2M1 SMARCA4 SMARCD1 SMARCD2 PRKDC CDC73 SAP130 TP53BP1 | 1.21e-05 | 1103 | 142 | 16 | 34189442 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERBB2 LRFN1 OBSCN REV3L GTF2IRD1 PLEKHG5 ITGB4 RYR1 ITPR3 TNRC18 MAP1S PIK3CD PAX2 LRRC14 PRKDC DNMBP | 1.24e-05 | 1105 | 142 | 16 | 35748872 |
| Pubmed | 1.26e-05 | 35 | 142 | 4 | 32504627 | ||
| Pubmed | USP24 REV3L RYR1 RYR2 KIF7 ITPR3 NBPF15 EXD3 SYNE2 SMARCD1 FGD5 ATP2B3 | 1.31e-05 | 638 | 142 | 12 | 31182584 | |
| Pubmed | Role of Wnt5a-Ror2 signaling in morphogenesis of the metanephric mesenchyme during ureteric budding. | 1.43e-05 | 12 | 142 | 3 | 24891614 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DDX17 MYO5A BMS1 ADAR TRIP12 STAU1 NOP9 AP2M1 RBM6 SMARCA4 PRKDC CDC73 SAP130 | 1.52e-05 | 759 | 142 | 13 | 35915203 |
| Pubmed | 1.54e-05 | 268 | 142 | 8 | 33640491 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DDX17 MYO5A DSG1 PMPCB BMS1 OAT PPP1R13L ADAR TRIP12 ITGB4 STAU1 ITPR3 AP2M1 SMARCA4 SMARCD2 PRKDC PATJ | 1.57e-05 | 1257 | 142 | 17 | 36526897 |
| Pubmed | 1.58e-05 | 37 | 142 | 4 | 24335282 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 25193700 | ||
| Pubmed | Emergence of Xin demarcates a key innovation in heart evolution. | 1.66e-05 | 2 | 142 | 2 | 18682726 | |
| Pubmed | Kinase signaling dysfunction in Parkinson's disease: a reverse genetic approach in Drosophila. | 1.66e-05 | 2 | 142 | 2 | 22486164 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 1.66e-05 | 2 | 142 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 1.66e-05 | 2 | 142 | 2 | 26009179 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 18586264 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 29092888 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 33178818 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 1.66e-05 | 2 | 142 | 2 | 15033925 | |
| Pubmed | Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies. | 1.66e-05 | 2 | 142 | 2 | 29880484 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 26102513 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 25500505 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 24285081 | ||
| Pubmed | Structural basis of SALM5-induced PTPδ dimerization for synaptic differentiation. | 1.66e-05 | 2 | 142 | 2 | 29348579 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 29348429 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19596993 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 1.66e-05 | 2 | 142 | 2 | 25370123 | |
| Pubmed | Structure, Expression, and Function of a Novel Intercalated Disc Protein, Xin. | 1.66e-05 | 2 | 142 | 2 | 16708114 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 16771836 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 17259277 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 23206244 | ||
| Pubmed | Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. | 1.66e-05 | 2 | 142 | 2 | 16901783 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 32899693 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 27975167 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 26823795 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 38547292 | ||
| Pubmed | ADAR1 controls apoptosis of stressed cells by inhibiting Staufen1-mediated mRNA decay. | 1.66e-05 | 2 | 142 | 2 | 28436945 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21723633 | ||
| Pubmed | Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma. | 1.66e-05 | 2 | 142 | 2 | 27775641 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 30542613 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 10662641 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 1.66e-05 | 2 | 142 | 2 | 11673493 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 11673462 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 22764206 | ||
| Pubmed | Common allosteric mechanisms between ryanodine and inositol-1,4,5-trisphosphate receptors. | 1.66e-05 | 2 | 142 | 2 | 21150295 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 23261932 | ||
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 1.66e-05 | 2 | 142 | 2 | 18618700 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.72e-05 | 357 | 142 | 9 | 37059091 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.76e-05 | 38 | 142 | 4 | 30786075 | |
| Pubmed | GPX8 USP28 RMI2 PPP1R13L GTF2IRD1 SMARCD1 SMARCD2 SMARCD3 SAP130 TP53BP1 | 1.83e-05 | 453 | 142 | 10 | 29656893 | |
| Interaction | ERG interactions | MYO5A ADAR TRIP12 RING1 PTPRD SMARCA4 SMARCD1 SMARCD2 SMARCD3 PRKDC | 3.45e-06 | 223 | 139 | 10 | int:ERG |
| Interaction | PSMD14 interactions | DDX17 DNAH10 AVPR1A BMS1 EFCAB2 PSMC2 APOB ECPAS HPS3 VPS13D SYNE2 SYTL1 PATJ GOLGA3 TP53BP1 | 3.73e-06 | 527 | 139 | 15 | int:PSMD14 |
| Interaction | SLX4 interactions | DDX17 DSG1 PMPCB SPART REV3L UBN2 ADAR STAU1 AP2M1 RBM6 SMARCA4 SMARCD3 PRKDC CDC73 TP53BP1 | 9.95e-06 | 572 | 139 | 15 | int:SLX4 |
| Interaction | OPALIN interactions | 1.50e-05 | 209 | 139 | 9 | int:OPALIN | |
| Interaction | ETS1 interactions | 2.09e-05 | 121 | 139 | 7 | int:ETS1 | |
| Interaction | MDC1 interactions | USP28 SH3KBP1 ADAR TRIP12 STAU1 BRAF SMARCA4 SMARCD1 SMARCD2 SMARCD3 PRKDC TP53BP1 | 3.07e-05 | 414 | 139 | 12 | int:MDC1 |
| GeneFamily | Neuroblastoma breakpoint family | 1.68e-09 | 23 | 95 | 6 | 662 | |
| GeneFamily | Fibronectin type III domain containing | 2.14e-05 | 160 | 95 | 7 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.23e-05 | 161 | 95 | 7 | 593 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 8.17e-05 | 3 | 95 | 2 | 287 | |
| GeneFamily | Paired boxes | 9.60e-04 | 9 | 95 | 2 | 675 | |
| GeneFamily | Parkinson disease associated genes | 3.12e-03 | 16 | 95 | 2 | 672 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 3.12e-03 | 16 | 95 | 2 | 14 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-08 | 192 | 142 | 9 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-07 | 184 | 142 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-07 | 184 | 142 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-07 | 184 | 142 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.20e-07 | 195 | 142 | 8 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 178 | 142 | 7 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 178 | 142 | 7 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-06 | 185 | 142 | 7 | daea170d827226dda6750bf1838ffd82f070c4d4 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 2.55e-06 | 189 | 142 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.55e-06 | 189 | 142 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.73e-06 | 191 | 142 | 7 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.73e-06 | 191 | 142 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.73e-06 | 191 | 142 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 192 | 142 | 7 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.82e-06 | 192 | 142 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 192 | 142 | 7 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.92e-06 | 193 | 142 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-06 | 194 | 142 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.13e-06 | 195 | 142 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.24e-06 | 196 | 142 | 7 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 3.58e-06 | 199 | 142 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.06e-05 | 155 | 142 | 6 | 00eef9f93a753a1fe1ab5fd8dae026e7be556cde | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.72e-05 | 169 | 142 | 6 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.78e-05 | 170 | 142 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-05 | 172 | 142 | 6 | 80b565f6e37f38629f4cf89d5b053b3b8517244e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-05 | 177 | 142 | 6 | 95760841b3f085d38c4926b258a33563d93a2016 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.31e-05 | 178 | 142 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 179 | 142 | 6 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.46e-05 | 180 | 142 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 181 | 142 | 6 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.54e-05 | 181 | 142 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 2.54e-05 | 181 | 142 | 6 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 182 | 142 | 6 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.62e-05 | 182 | 142 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.70e-05 | 183 | 142 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.70e-05 | 183 | 142 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.78e-05 | 184 | 142 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.78e-05 | 184 | 142 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.87e-05 | 185 | 142 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.87e-05 | 185 | 142 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-05 | 186 | 142 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.05e-05 | 187 | 142 | 6 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.05e-05 | 187 | 142 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.14e-05 | 188 | 142 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.14e-05 | 188 | 142 | 6 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 189 | 142 | 6 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 3.33e-05 | 190 | 142 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-05 | 190 | 142 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-05 | 191 | 142 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.43e-05 | 191 | 142 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.43e-05 | 191 | 142 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 191 | 142 | 6 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 191 | 142 | 6 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-05 | 191 | 142 | 6 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 191 | 142 | 6 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 191 | 142 | 6 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.43e-05 | 191 | 142 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 192 | 142 | 6 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 192 | 142 | 6 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | Control-Fibroblasts-Vascular_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.64e-05 | 193 | 142 | 6 | 60e44aac8be0430ad35e20eb98b1b700d76a0427 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.64e-05 | 193 | 142 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 3.64e-05 | 193 | 142 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.64e-05 | 193 | 142 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 194 | 142 | 6 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.74e-05 | 194 | 142 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-05 | 195 | 142 | 6 | 9fea1ddb68da83ca43dd8006c9e51295b1817f0e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.96e-05 | 196 | 142 | 6 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 196 | 142 | 6 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 196 | 142 | 6 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-05 | 196 | 142 | 6 | 614a07334707eafe238d5cb7b080a3ca796a1920 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-05 | 196 | 142 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.96e-05 | 196 | 142 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 3.96e-05 | 196 | 142 | 6 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.96e-05 | 196 | 142 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.08e-05 | 197 | 142 | 6 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.08e-05 | 197 | 142 | 6 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.19e-05 | 198 | 142 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.19e-05 | 198 | 142 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.31e-05 | 199 | 142 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 4.31e-05 | 199 | 142 | 6 | cf592d93612023a13de21e0fb8c6b13714f9af71 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.31e-05 | 199 | 142 | 6 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 4.43e-05 | 200 | 142 | 6 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.43e-05 | 200 | 142 | 6 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.43e-05 | 200 | 142 | 6 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.43e-05 | 200 | 142 | 6 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 200 | 142 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.43e-05 | 200 | 142 | 6 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.43e-05 | 200 | 142 | 6 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 200 | 142 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 4.43e-05 | 200 | 142 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.43e-05 | 200 | 142 | 6 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.43e-05 | 200 | 142 | 6 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 200 | 142 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.43e-05 | 200 | 142 | 6 | be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.50e-05 | 122 | 142 | 5 | aca079f2f033cc1ac13c4ee02d490b6a514cbd5c | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.50e-05 | 122 | 142 | 5 | ac38130010f76648757eac700a8039f3960ddde3 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.50e-05 | 122 | 142 | 5 | 7ab0b63244116e74c5783c3293cf08224d094d0a | |
| ToppCell | Thalamus-Macroglia-CSF_related|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.50e-05 | 122 | 142 | 5 | eb944243424460bf5c66aced3ed7b7a1b6486ac7 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.50e-05 | 122 | 142 | 5 | 9b0d6b0a394560ff5aadcd3b21519c2393e6def8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 153 | 142 | 5 | d6526d17826470534b766df144c74e73eb83fdad | |
| Disease | alcohol use disorder (implicated_via_orthology) | ERBB2 DDX17 RYR1 RYR2 PIK3CD SMARCA4 SMARCD1 SMARCD2 SMARCD3 | 2.07e-07 | 195 | 129 | 9 | DOID:1574 (implicated_via_orthology) |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 6.73e-06 | 9 | 129 | 3 | DOID:1925 (implicated_via_orthology) | |
| Disease | seropositivity measurement, Influenza A seropositivity | 1.90e-05 | 2 | 129 | 2 | EFO_0007034, EFO_0007038 | |
| Disease | cancer (implicated_via_orthology) | 2.47e-05 | 268 | 129 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 5.67e-05 | 3 | 129 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 5.67e-05 | 3 | 129 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 6.57e-05 | 96 | 129 | 5 | C1319315 | |
| Disease | Malignant tumor of colon | 7.34e-05 | 159 | 129 | 6 | C0007102 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 9.31e-05 | 166 | 129 | 6 | EFO_0004530, EFO_0004611 | |
| Disease | Anhydrotic Ectodermal Dysplasias | 1.13e-04 | 4 | 129 | 2 | C1706004 | |
| Disease | coronary artery disease, factor VII measurement | 1.31e-04 | 111 | 129 | 5 | EFO_0001645, EFO_0004619 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.31e-04 | 111 | 129 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | chronotype measurement | AVPR1A PSMC2 DUS3L ESYT3 EXD3 PTPRD CCDC87 DCHS1 RBM6 ROBO2 PAX5 PATJ NPAS2 | 1.35e-04 | 882 | 129 | 13 | EFO_0008328 |
| Disease | lipoprotein A measurement | 1.36e-04 | 112 | 129 | 5 | EFO_0006925 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.50e-04 | 61 | 129 | 4 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.68e-04 | 264 | 129 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.74e-04 | 118 | 129 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | Cetuximab response | 1.88e-04 | 5 | 129 | 2 | cv:CN077967 | |
| Disease | Hidrotic Ectodermal Dysplasia | 1.88e-04 | 5 | 129 | 2 | C0162361 | |
| Disease | Panitumumab response | 1.88e-04 | 5 | 129 | 2 | cv:CN077999 | |
| Disease | Lymphatic Metastasis | 1.97e-04 | 26 | 129 | 3 | C0024232 | |
| Disease | Cholangiocarcinoma | 1.97e-04 | 26 | 129 | 3 | C0206698 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 1.97e-04 | 26 | 129 | 3 | OBA_2045191 | |
| Disease | Autosomal Dominant Parkinsonism | 2.47e-04 | 28 | 129 | 3 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 2.47e-04 | 28 | 129 | 3 | C0752097 | |
| Disease | Parkinsonism, Experimental | 2.47e-04 | 28 | 129 | 3 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 2.47e-04 | 28 | 129 | 3 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 2.47e-04 | 28 | 129 | 3 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 2.47e-04 | 28 | 129 | 3 | C0242423 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 2.47e-04 | 28 | 129 | 3 | C1868675 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.54e-04 | 128 | 129 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.54e-04 | 128 | 129 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.54e-04 | 128 | 129 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.54e-04 | 128 | 129 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.54e-04 | 128 | 129 | 5 | C0007134 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.56e-04 | 200 | 129 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | Colorectal Carcinoma | OBSCN APOB TYMP HPS3 PROM1 CORO2B DLC1 PTPRD BRAF DCHS1 NLRP8 | 2.68e-04 | 702 | 129 | 11 | C0009402 |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 2.74e-04 | 29 | 129 | 3 | C0496920 | |
| Disease | Ectodermal Dysplasia | 2.81e-04 | 6 | 129 | 2 | C0013575 | |
| Disease | Aplasia Cutis Congenita | 2.81e-04 | 6 | 129 | 2 | C0282160 | |
| Disease | Ovarian Carcinoma | 3.04e-04 | 30 | 129 | 3 | C0029925 | |
| Disease | Parkinsonism, Juvenile | 3.04e-04 | 30 | 129 | 3 | C0752105 | |
| Disease | Parkinsonian Disorders | 3.04e-04 | 30 | 129 | 3 | C0242422 | |
| Disease | ovarian neoplasm | 3.14e-04 | 134 | 129 | 5 | C0919267 | |
| Disease | vital capacity | DENND2A CAND2 KIF1A PCDHA10 APOB TRIP12 RYR2 STAU1 PTPRD BRAF PDIK1L SMARCD2 PAX2 DUSP10 PATJ | 3.38e-04 | 1236 | 129 | 15 | EFO_0004312 |
| Disease | Malignant neoplasm of ovary | 3.48e-04 | 137 | 129 | 5 | C1140680 | |
| Disease | palmitoyl dihydrosphingomyelin (d18:0/16:0) measurement | 3.93e-04 | 7 | 129 | 2 | EFO_0800400 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.47e-04 | 222 | 129 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.68e-04 | 224 | 129 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.96e-04 | 148 | 129 | 5 | C0279702 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 5.22e-04 | 8 | 129 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | Unilateral agenesis of kidney | 5.22e-04 | 8 | 129 | 2 | C0266294 | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 5.22e-04 | 8 | 129 | 2 | DOID:5520 (is_marker_for) | |
| Disease | common bile duct neoplasm (is_marker_for) | 5.22e-04 | 8 | 129 | 2 | DOID:4608 (is_marker_for) | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 5.27e-04 | 150 | 129 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | Colonic Neoplasms | 5.60e-04 | 152 | 129 | 5 | C0009375 | |
| Disease | heart disease (implicated_via_orthology) | 6.16e-04 | 38 | 129 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Non-Small Cell Lung Carcinoma | 6.29e-04 | 156 | 129 | 5 | C0007131 | |
| Disease | Tendinopathy | 6.69e-04 | 9 | 129 | 2 | EFO_1001434 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.71e-04 | 41 | 129 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 7.71e-04 | 41 | 129 | 3 | C0858252 | |
| Disease | Head and Neck Carcinoma | 8.34e-04 | 10 | 129 | 2 | C3887461 | |
| Disease | Malignant neoplasm of breast | ERBB2 XIRP1 OBSCN ADAR NOP9 PTPRD BRAF SYNE2 SMARCD1 FGD5 RUSF1 TP53BP1 NLRP8 | 8.74e-04 | 1074 | 129 | 13 | C0006142 |
| Disease | triglycerides in large LDL measurement | 8.87e-04 | 43 | 129 | 3 | EFO_0022319 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 8.87e-04 | 43 | 129 | 3 | EFO_0022290 | |
| Disease | saturated fatty acids measurement | 1.01e-03 | 45 | 129 | 3 | EFO_0022304 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.10e-03 | 103 | 129 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.22e-03 | 12 | 129 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Hirschsprung's disease (implicated_via_orthology) | 1.22e-03 | 12 | 129 | 2 | DOID:10487 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.38e-03 | 50 | 129 | 3 | EFO_0022334 | |
| Disease | putamen volume change measurement | 1.43e-03 | 13 | 129 | 2 | EFO_0021495 | |
| Disease | Carcinogenesis | 1.43e-03 | 13 | 129 | 2 | C0596263 | |
| Disease | triglycerides to total lipids in large LDL percentage | 1.46e-03 | 51 | 129 | 3 | EFO_0022331 | |
| Disease | phospholipids in very small VLDL measurement | 1.46e-03 | 51 | 129 | 3 | EFO_0022300 | |
| Disease | PR interval | 1.54e-03 | 495 | 129 | 8 | EFO_0004462 | |
| Disease | factor VIII measurement, coronary artery disease | 1.55e-03 | 113 | 129 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | Neoplasm of lung | 1.67e-03 | 14 | 129 | 2 | cv:C0024121 | |
| Disease | cerebellum cortex volume change measurement | 1.67e-03 | 14 | 129 | 2 | EFO_0021497 | |
| Disease | Lung cancer | 1.67e-03 | 14 | 129 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 1.67e-03 | 14 | 129 | 2 | 211980 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.67e-03 | 14 | 129 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Metastatic melanoma | 1.72e-03 | 54 | 129 | 3 | C0278883 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.81e-03 | 291 | 129 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | triglycerides in medium VLDL measurement | 1.81e-03 | 55 | 129 | 3 | EFO_0022155 | |
| Disease | leukemia | 1.81e-03 | 55 | 129 | 3 | C0023418 | |
| Disease | triglycerides in large VLDL measurement | 1.91e-03 | 56 | 129 | 3 | EFO_0022178 | |
| Disease | triglycerides in LDL measurement | 1.91e-03 | 56 | 129 | 3 | EFO_0022320 | |
| Disease | Generalized hypotonia | 1.92e-03 | 15 | 129 | 2 | C1858120 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.00e-03 | 121 | 129 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | Hypertrophic Cardiomyopathy | 2.01e-03 | 57 | 129 | 3 | C0007194 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 2.19e-03 | 16 | 129 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | phospholipids in small VLDL measurement | 2.33e-03 | 60 | 129 | 3 | EFO_0022146 | |
| Disease | obsolete_red blood cell distribution width | SYN3 RC3H1 RMI2 APOB TYMP PLEKHG5 SLC4A1 ESYT3 SYNE2 RBM6 LRRC14 HOOK2 ATP2B3 SLC30A10 | 2.33e-03 | 1347 | 129 | 14 | EFO_0005192 |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.38e-03 | 127 | 129 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | triglycerides in small VLDL measurement | 2.44e-03 | 61 | 129 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 2.44e-03 | 61 | 129 | 3 | EFO_0022274 | |
| Disease | Disorder of eye | 2.45e-03 | 212 | 129 | 5 | C0015397 | |
| Disease | Benign neoplasm of stomach | 2.47e-03 | 17 | 129 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.47e-03 | 17 | 129 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.47e-03 | 17 | 129 | 2 | C0154060 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IPAREIPDLLEKGER | 926 | P04626 | |
| LRVILEPLLVDKPFV | 221 | A0FGR9 | |
| RDERPLFPQILASIE | 701 | P15056 | |
| ESLLNPELIRPFILE | 331 | Q8IZL9 | |
| ENIPVVRRPDRKDLL | 81 | Q6P1J9 | |
| AELEAVELPVPIRFL | 251 | P02730 | |
| DPNRDVISPLLVAIR | 436 | Q96Q27 | |
| DLRAPVVFVLVPLRD | 286 | Q8WW27 | |
| PLLVPDNRRLFELEE | 261 | Q9NZN4 | |
| EDDPLRRPITIALVE | 711 | Q9UK96 | |
| PQVIRKIRVEQFPDA | 1476 | Q96L96 | |
| ITEQELPERRKALRP | 596 | Q6XZF7 | |
| VPVGLLERLPQRINE | 586 | Q96G46 | |
| FPENRSPEEIREKIL | 1021 | Q96PN6 | |
| EDPAVDVIRKLLQLP | 1251 | Q9P1Z9 | |
| PPEARLRLIKVILDE | 76 | Q9NVE4 | |
| EDHVPPVLRLLEKRQ | 26 | A6NFT4 | |
| PAVIREPHERKILAL | 1196 | Q14692 | |
| DVVPPNVRDLLDILR | 31 | O15519 | |
| RDFQPVREQIPEDKL | 556 | Q16720 | |
| VLVLFVVQRLEPRFP | 221 | Q5TC82 | |
| KPLPSAEREQLRLEL | 956 | Q5TC82 | |
| TNVPIDIEEERPIRL | 401 | Q14573 | |
| RPLPDVVRQRIVELA | 31 | Q02548 | |
| QVLESRLQRPLPEDL | 546 | O75427 | |
| PPNIDRRTVELRLAD | 46 | Q96NI6 | |
| VRVERRQELALEDPP | 356 | Q99743 | |
| FLQPDITERLPRDLR | 191 | Q7RTW8 | |
| RRIPIPELEARIDAV | 431 | O75439 | |
| RPLDREVEPAFQLRI | 1811 | Q96JQ0 | |
| RPIPEDVLLRAFEVL | 226 | Q5VUJ9 | |
| LLVLEPPRLQSLFEE | 336 | Q86U38 | |
| LRFLREPVVTPQDLE | 451 | Q66K74 | |
| QEKIPELRRRGLPVA | 16 | Q96JY0 | |
| ISLQEIPPERRRKLE | 1081 | Q02846 | |
| VVRREINAILPTLEP | 116 | Q86W28 | |
| QAPVTEILRQPERLL | 231 | Q86W26 | |
| EILRQPERLLFILDG | 236 | Q86W26 | |
| ELQRKREYIEELEPP | 556 | Q96ED9 | |
| LLFVPPAIDRRVVEL | 56 | Q9P244 | |
| PITLRVNVRPVDDEV | 926 | Q5SZK8 | |
| VQEEVRALRLCPLEP | 696 | Q8ND23 | |
| RALRLCPLEPVQDEL | 701 | Q8ND23 | |
| LDDRVVVALSRPVRP | 6 | Q9Y6W6 | |
| RGRPLDDIIDKLPEI | 1191 | Q5VYK3 | |
| FRVRDIGELVPLLPN | 241 | Q86V42 | |
| ESVPPDVRQLVRALL | 476 | Q9BXM7 | |
| ALVELRPENLLLVAP | 301 | Q6ZS72 | |
| IVVPRVPLREDEPKD | 66 | Q6ZNL6 | |
| IPVEDKRPEEIIQIL | 191 | Q5T2T1 | |
| AEEAPVRVALRVRPL | 11 | Q2M1P5 | |
| VPIEFPVIDRKRLLQ | 1541 | Q5S007 | |
| KDIILPFRVIPLVRE | 281 | Q96CW1 | |
| PLPLEKEEQVRLQAR | 141 | Q08378 | |
| LVRLGPDQVPLREEF | 461 | Q9C091 | |
| LVDVRVPLFIRPEDD | 941 | P16144 | |
| LELRVRVLDINDNPP | 141 | Q02413 | |
| RPLPDVVRQRIVELA | 31 | Q02962 | |
| PVLVLRKLLDREENP | 191 | Q9Y5I2 | |
| IVRERPAAIIKPLED | 2821 | Q5VST9 | |
| AGVRLPEIKEREPLE | 236 | Q92772 | |
| LKVEDIPLARITLPD | 2696 | P04114 | |
| LRRPVNVPLDIFLEE | 106 | P17658 | |
| LLENVPPRTENELLR | 426 | Q9UQ03 | |
| VIKLENRQEARPEPA | 416 | P55265 | |
| QREISPEEPLRRLQE | 171 | Q96P09 | |
| PLLRELPLEEVLVVD | 826 | Q9ULE3 | |
| IVFLVRLLPETPREA | 901 | Q9P218 | |
| RLRQKVLREPLEPAA | 676 | Q2TAC2 | |
| VLREPLEPAALQREL | 681 | Q2TAC2 | |
| REAVLIDPVLETAPR | 46 | O95571 | |
| FEPQIRKILLDVRPD | 386 | Q86TM3 | |
| NKLRRDIVPEALFLP | 686 | P55285 | |
| PNEDIVERNIRIIVP | 51 | P01591 | |
| EPQIRKIVDQIRPDR | 336 | Q92841 | |
| LRPIKIEPEDLDIIQ | 491 | Q9UHL9 | |
| PIEVIRPDIAALVRQ | 186 | Q8TED1 | |
| APVLQRVDRLIEPLR | 1141 | O75155 | |
| PELSPEEQRVLERKL | 56 | Q9BRJ6 | |
| DILEREIPLSQPFRL | 3381 | Q8IVF4 | |
| VLPPHLERIREKLAE | 861 | P21817 | |
| QIVLPPHLERIREKL | 871 | Q92736 | |
| ELEEVARVLAEIPRP | 506 | Q8WUF5 | |
| EIELVFRPHPLLVEK | 261 | Q06587 | |
| LLREKLETAQRPVPE | 1396 | Q12756 | |
| RLLVPDIQEIRVSPI | 1561 | Q12756 | |
| VLRIQPLRTPRDEAI | 81 | P23468 | |
| ELKDELPERQPRFIV | 56 | P60983 | |
| PLPAELEELRNRVRA | 396 | Q96GQ5 | |
| KLREVVETPLLHPER | 186 | P35998 | |
| EPRLTIDEAPQERLR | 136 | Q8IYJ3 | |
| PIVQRPRILLVIDDA | 86 | O14994 | |
| EALRVVKILQNLDPP | 711 | P78332 | |
| PPLKVLAEQLRRDAE | 21 | Q96E14 | |
| KILPQRIRELVPESQ | 131 | Q96GM5 | |
| FRIAEQELKIPRLLE | 246 | Q8WXH0 | |
| ILLTKAEPEAIPERR | 446 | Q969F9 | |
| PRLSRELLEVVEPEV | 936 | P0DPF3 | |
| PRLSRELLEVVEPEV | 1011 | Q6P3W6 | |
| PRLSRELLEVVEPEV | 2231 | Q6P3W6 | |
| PRLSRELLEVVEPEV | 3451 | Q6P3W6 | |
| PRLSRELLEVVEPEV | 746 | Q5TI25 | |
| PRLSRELLEVVEPEV | 496 | Q8N660 | |
| PRLSRELVEVVEPEV | 496 | A0A087WUL8 | |
| PRLSRELLEVVEPEV | 1716 | A0A087WUL8 | |
| PRLSRELLEVVEPEV | 2936 | A0A087WUL8 | |
| PRLSRELLEVVEPEV | 396 | P0DPF2 | |
| PRLSRELLEVVEPEV | 1616 | P0DPF2 | |
| PRLSRELLEVVEPEV | 2836 | P0DPF2 | |
| PRLSRELLEVVEPEV | 4056 | P0DPF2 | |
| PQDRPDAFELELRLV | 316 | Q8N165 | |
| ILDRLRPNIIPVLDE | 241 | O43490 | |
| LRPRSIEVENDFLPV | 226 | Q96B97 | |
| QKPRGLDPVEILQER | 356 | P51532 | |
| KILPQRIRELVPESQ | 106 | Q6STE5 | |
| LKNDAPVVQEPRRII | 96 | Q01974 | |
| VIEVPAVPEEILKRL | 1371 | Q96QB1 | |
| IIRFAPPLVIKEDEL | 411 | P04181 | |
| ADKVLPQRIRELVPE | 141 | Q92925 | |
| ALVPREREPKLSILQ | 6 | Q8WZ69 | |
| LSQRLADPEVLKRPE | 116 | O95628 | |
| LRIPQERLQATEEPR | 211 | Q96EG3 | |
| DAVEIIRKVAVPPRL | 3116 | A4UGR9 | |
| ERLLDAVVPFLPLQR | 251 | Q5JU69 | |
| PRRPGEEAELLVKLD | 2451 | O15417 | |
| AERTRVIRPPLLVDK | 621 | O94827 | |
| VLRLARPERIDDPEL | 101 | Q6XR72 | |
| LRERIQPEEKPVEVS | 456 | Q8N0X7 | |
| ILIIPTPDEEEKILR | 11 | P17028 | |
| RPPRETVRLELVLKD | 121 | Q6ZU65 | |
| LRRVQDVKLQPPEVV | 251 | Q96F44 | |
| PLIQLVRRPVEVLQD | 2961 | O60673 | |
| VRRPVEVLQDPTLRL | 2966 | O60673 | |
| ALRILQNEPLPERLE | 156 | O95793 | |
| PSLLIDLPVVAQRRE | 996 | Q8NI35 | |
| AVPEVRLPEVQLLKV | 511 | Q9BXM0 | |
| AVPLIQPDLRREEAV | 16 | Q6VEQ5 | |
| LQSREEKQEPVVVRP | 86 | Q9H0E3 | |
| AVPLIQPDLRREEAV | 16 | C4AMC7 | |
| DVQPFLPVLRLVARE | 91 | O00329 | |
| QELKPERLQPRIDRL | 2181 | Q9H254 | |
| VEDRLRAIVADPRVP | 46 | A0A0J9YWL9 | |
| EALEIPRPLRALDQT | 1226 | Q9HCK4 | |
| PLVRADDPLRLDQEL | 836 | Q12888 | |
| PRLLDPSAEIIVLKE | 1031 | Q96RU2 | |
| PPRDVRNEELAKLEI | 41 | P37288 | |
| LKPVELRELLNPVVE | 2446 | P78527 | |
| LIELVAERIKQDPIP | 211 | Q9UPU5 | |
| ADLYVRRIPLEDIPE | 251 | Q9NRZ5 | |
| PVKIDPLALVQAIER | 1286 | Q14669 | |
| ELPRIICQVLRRPDV | 826 | Q702N8 | |
| LLPRAREQEELLAPA | 371 | P19971 | |
| PRKTREPFILEENEI | 1346 | Q5THJ4 | |
| APIPVEVRVDLRVNR | 161 | Q15048 | |
| IIDEPIRPVNIPRKE | 1456 | Q9Y4I1 | |
| PEERLPAAVAVELRR | 326 | Q8N9H8 |